Cytokinetics Aktie
68,60
EUR
+1,06
EUR
+1,57
%
78,77
USD
+0,59
USD
+0,75
%
Cytokinetics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Cytokinetics Aktie Analyse
| 21.09.18 | Cytokinetics Overweight | Cantor Fitzgerald | |
| 22.11.17 | Cytokinetics Buy | Needham & Company, LLC | |
| 21.11.17 | Cytokinetics Buy | H.C. Wainwright & Co. | |
| 08.03.17 | Cytokinetics Buy | Rodman & Renshaw, LLC | |
| 06.02.17 | Cytokinetics Strong Buy | Needham & Company, LLC | |
| 16.12.16 | Cytokinetics Overweight | Cantor Fitzgerald | |
| 10.11.15 | Cytokinetics Outperform | FBR Capital | |
| 09.11.15 | Cytokinetics Buy | ROTH Capital Partners, LLC | |
|
Werbung
|
|||
| 24.07.15 | Cytokinetics Buy | MLV Capital | |
| 31.12.14 | Cytokinetics Buy | ROTH Capital Partners, LLC | |
| 04.11.14 | Cytokinetics Buy | MLV Capital | |
| 03.07.12 | Cytokinetics buy | Needham & Company, LLC | |
| 20.05.08 | Cytokinetics | Global Biotech Investing | |
Werbung
Werbung